Category: Blog
Bloomberg Interview 7.13.2012 The Apple of Andrew Keene's Eye
Bloomberg Interview 7.13.2012 Options Playbook: Track Movement
Bloomberg Interview 7.13.2012 How Will JPMorgan Make Money Going Forward?
Bloomberg Interview 7.13.2012 Maki Says Fed `Data Watching' Before a QE Decision
Bloomberg Interview 7.13.2012 Citi's Long Growth Good, Global Banking Weak
Bloomberg Interview 7.13.2012 Should Investors Fear the Big Bad VIX?
Bloomberg Interview 7.13.2012 Volatility Is Going to Creep Up
Halftime Report 7.16.2012
Citi kicked off the day with stronger-than-expected earnings of $1, analysts expected 89 cents. C reported a 12% fall in net income to $2.9 billion. Revenue for the quarter was $18.6 billion, down from $18.8 last year.
S&P 500 futures were down 2.5 points at 1349.25, NASDAQ futures traded flat at 2577.00, and Dow Jones Industrial Average futures fell 34 points to 12678.00.
EUR/USD futures started the day making lows of $1.2184 to then trade up to the current $1.2274.
Gold futures were nearly flat with a gain of 80 cents to $1592.80 and WTI crude futures gained 65 cents to $87.75.
MasterCard Inc. rose over 3% after reaching a settlement with several large banks over an antitrust lawsuit on credit card processing fees.
Arch Coal fell 7.82% after BMO analysts cut their recommendation for the stock due to weak balance sheets.
David Cornes holds a degree in economics from the University of Montana.
Movers and Shakers – PRX – 7.16.2012
Private equity group TPG agreed to buy out the pharma company for a premium of 37% over Friday’s closing price, deal valued at about $1.9 billion. PRX is a specialty pharmaceutical company that develops, manufactures and markets drugs that typically have a high barrier of entry. TPG, a private equity group with $51.5 billion in assets is known for its investments in the healthcare sector.
David Cornes holds a degree in economics from the University of Montana.